Complication of bacterial pneumonia: empyema and lung abscess
Abstract
Bacterial pneumonia is the inflammation of the lung parenchyma due to an infectious agent. This condition causes more illness and death than any other infection and constitutes a health problem affecting all countries; however, two-thirds of deaths from this cause occur in low-income countries. Empyema and lung abscess are among the most frequent complications, but these are more commonly attributed to immunocompromised patients. The clinical course of a complicated bacterial pneumonia in a 41-year-old white apparently healthy male patient, with no prior medical history who presented with fever, chest pain and a productive cough is described. In this case, a secondary lung abscess developed as a complication of pneumonia, but none of the aforementioned risk factors were present, nor were any diseases affecting the immune system detected during the diagnostic workup. This case demonstrates that complications can occur even in apparently healthy young patients.
Downloads
References
1.Gea Izquierdo E. Neumonía: La pandemia ignorada. Vive. Revista de Investigación en Salud. 2021(citado 20/12/2025);4(12):437-42. Disponible en https://revistavive.org/index.php/revistavive/article/view/122/337
2. Clínic de Barcelona. Barcelona: Hospital Clínic; 2026 [actualización 3 /11/2021; citado 11/12/2025]. La neumonía causa 2,5 millones de muertes al año en todo el mundo; [aprox. 4p.]. Disponible en: https://www.clinicbarcelona.org/noticias/la-neumonia-causa-2-5-millones-de-muertes-al-ano-en-todo-el-mundo
3.El economista. México; © 1988-2015[actualización 18 /10/2025; citado 11/12/2025]. Solo el 40 % de adultos mayores se vacunan para prevenir la neumonía. Pfizer México; [aprox. 4p.]. Disponible en: https://www.eleconomista.com.mx/estados/40-adultos-mayores-vacunan-prevenir-neumonia-pfizer-mexico-20251018-782414.html
4. Cuba. Ministerio de Salud Pública. Dirección de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2024. La Habana: Dirección de Registros Médicos y Estadísticas de Salud; 2025[citado 16/04/2026]. Disponible en: https://files.sld.cu/dne/files/2025/09/AES-2024-para-sitio-3.pdf
5.Álvarez Aliaga A, Frómeta Guerra A, López Costa C, Berdú Saumell Y, Soto Brown C. Factores de riesgo de muerte por bronconeumonía bacteriana comunitaria. Rev cubana med. 2009(citado 22/12/2025);48(4):163-72. Disponible en http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232009000400004
6.HelpGuide. Los Angeles: HelpGuide. Org International; ©1999-2026. [actualización 1 /04/2026; citado 11/05/2026]. Envejecimiento y consumo de alcohol. Disponible en: https://www.helpguide.org/es/problemas-del-envejecimiento/el-alcohol-y-los-adultos-mayores
7. MedlinePlus. Bethesda (MD): Biblioteca Nacional de Medicina (EE. UU.); [actualizado 19/08/2024; citado 11/12/2025]. Neumonía en adultos, adquirida en la comunidad; [aprox. 5p.]. Disponible en https://medlineplus.gov/spanish/ency/article/000145.htm
8.Aryana WF, Wibowo A, Gozali A, Sapura TT, Feribaharati I. Uncontroled Type 2 Diabetes Mellitus Induce an Enteroccoccus faecalis Lung Abscess: A case report. Medula. 2024(citado 20/12/2025):14(8):1521. Disponible en: https://www.journalofmedula.com/index.php/medula/article/view/1184/954
9.Sabbula BR, Rammohan G, Sharma S, Akea J. Absceso pulmonar. Stat Pearls. 2024 (citado 22/12/2025). Disponible en: https://www-ncbi-nlm-nih-gov.translate.goog/books/NBK555920/?_x_tr_sl=en&_x_tr_tl=es&_x_tr_hl=es&_x_tr_pto=tc
10.Issa MA, Obadiel YA, Galeb KS,Jowah HM. Impact of initial surgical interventions on Empyema Outocomes: Insights from a cohort study in Yemen. Cureus. 2024(citado 23/12/2025):16(9):e69059. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC11465397/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Yazmin Almenares Castellanos, Yanelis González Díaz

This work is licensed under a Creative Commons Attribution 4.0 International License.
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
